Gene: PRR11
Official Full Name: proline rich 11provided by HGNC
Gene Summary: Involved in regulation of cell cycle. Located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14865 | PRR11 Knockout cell line (HeLa) | Human | PRR11 | 1:3~1:6 | Negative | Online Inquiry |
KO14866 | PRR11 Knockout cell line (HCT 116) | Human | PRR11 | 1:2~1:4 | Negative | Online Inquiry |
KO14867 | PRR11 Knockout cell line (HEK293) | Human | PRR11 | 1:3~1:6 | Negative | Online Inquiry |
KO14868 | PRR11 Knockout cell line (A549) | Human | PRR11 | 1:3~1:4 | Negative | Online Inquiry |
PRR11 Gene Knockout Cell Lines are genetically engineered cellular models designed specifically to study the role and function of the PRR11 gene, which is implicated in various cellular processes, including cell cycle regulation and tumorigenesis. By creating precise knockout variants of this gene, researchers can investigate its biological pathways and contribute to a deeper understanding of mechanisms underlying diseases, particularly cancer.
These cell lines operate through the systematic deletion of the PRR11 gene, facilitated by CRISPR-Cas9 or other advanced genome editing technologies. This process helps elucidate the gene's functions by allowing scientists to compare the phenotypic and molecular characteristics of knockout cells with their wild-type counterparts. Such comparisons reveal critical insights into cellular behavior, including proliferation rates, apoptosis, and the response to therapy, making these cell lines invaluable for translational studies.
The scientific importance of PRR11 Gene Knockout Cell Lines extends beyond basic research into applied biomedical sciences. In a clinical context, they can inform targeted therapeutic strategies and drug resistance mechanisms, offering a gateway for the development of novel cancer treatments that effectively address PRR11-related malignancies.
One of the standout advantages of our PRR11 Gene Knockout Cell Lines is their rigorously verified genome editing, ensuring high specificity and reduced off-target effects compared to alternative methods. Additionally, the comprehensive validation accompanying these cell lines guarantees reproducibility and reliability for high-stakes research applications.
By integrating the advanced capabilities of our PRR11 Gene Knockout Cell Lines into their research, scientists and clinicians can gain a sharper understanding of gene functionalities and disease mechanisms. This not only accelerates the pace of discovery but also enhances therapeutic approaches, making this product an indispensable resource in modern biological research.
Our company prides itself on leading-edge solutions and profound expertise in genetic engineering and cellular biology, ensuring that our products empower researchers with the tools they need to excel in their scientific endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.